
T2D Treatment | Glyxambi® (empagliflozin/linagliptin) tablets
With diet and exercise, GLYXAMBI lowers A1C in adults with type 2 diabetes. Learn how it works and about its side effects. View ISI, PI and Med Guide.
Glyxambi: Uses, Dosage, Side Effects & Warnings - Drugs.com
Nov 13, 2024 · Glyxambi is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Glyxambi is also used to lower the risk of death from heart attack, …
Glyxambi (empagliflozin/linagliptin): Uses, Side Effects ... - WebMD
Jul 21, 2024 · Find patient medical information for Glyxambi (empagliflozin/linagliptin) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Glyxambi (empagliflozin / linagliptin): Uses, Side Effects ... - GoodRx
Nov 22, 2024 · Learn about Glyxambi (empagliflozin / linagliptin) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
Glyxambi (Empagliflozin and Linagliptin Tablets): Side Effects ... - RxList
Nov 16, 2023 · Glyxambi (Empagliflozin and Linagliptin Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison …
Patients should be informed of the characteristic symptoms of acute pancreatitis. If pancreatitis is suspected, Glyxambi should be discontinued; if acute pancreatitis is confirmed, Glyxambi should not …
GLYXAMBI- empagliflozin and linagliptin tablet, film coated - DailyMed
Oct 9, 2025 · GLYXAMBI is a combination of empagliflozin and linagliptin indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Empagliflozin and linagliptin Uses, Side Effects & Warnings
Nov 3, 2025 · What is empagliflozin and linagliptin? Empagliflozin and linagliptin is a combination medicine used together with diet and exercise to improve blood sugar control in adults with type 2 …
Glyxambi (empagliflozin and linagliptin) - MedicineNet
Glyxambi (empagliflozin and linagliptin) is a prescription medication that contains two diabetes medicines, empagliflozin (Jardiance) and linagliptin (Tradjenta), and is used to treat diabetes type 2.
Glyxambi - European Medicines Agency (EMA)
Jun 30, 2025 · Glyxambi, fixed dose combination of empagliflozin and linagliptin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus: to improve glycaemic control when metformin …